Boxer Capital Management as of March 31, 2025
Portfolio Holdings for Boxer Capital Management
Boxer Capital Management holds 28 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 14.0 | $47M | 1.3M | 35.36 | |
| Nuvalent Inc-a (NUVL) | 9.6 | $32M | 450k | 70.92 | |
| Merus N V (MRUS) | 8.9 | $30M | 700k | 42.09 | |
| Avidity Biosciences Ord (RNA) | 7.7 | $26M | 865k | 29.52 | |
| Anaptysbio Inc Common (ANAB) | 7.3 | $24M | 1.3M | 18.59 | |
| Xenon Pharmaceuticals (XENE) | 6.1 | $20M | 600k | 33.55 | |
| Replimune Group (REPL) | 5.3 | $18M | 1.8M | 9.75 | |
| Apellis Pharmaceuticals (APLS) | 4.7 | $16M | 713k | 21.87 | |
| Chimerix (CMRX) | 4.6 | $15M | 1.8M | 8.51 | |
| Tango Therapeutics (TNGX) | 4.3 | $14M | 10M | 1.37 | |
| Enliven Therapeutics (ELVN) | 4.0 | $13M | 671k | 19.68 | |
| Oric Pharmaceuticals (ORIC) | 2.9 | $9.7M | 1.7M | 5.58 | |
| Day One Biopharmaceuticals I (DAWN) | 2.8 | $9.4M | 1.2M | 7.93 | |
| Kymera Therapeutics (KYMR) | 2.7 | $8.9M | 325k | 27.37 | |
| Prothena Corp SHS (PRTA) | 2.6 | $8.5M | 690k | 12.38 | |
| Uniqure Nv SHS (QURE) | 2.4 | $8.0M | 750k | 10.60 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.0 | $6.8M | 200k | 33.93 | |
| Nurix Therapeutics (NRIX) | 2.0 | $6.7M | 563k | 11.88 | |
| Amylyx Pharmaceuticals (AMLX) | 1.9 | $6.2M | 1.8M | 3.54 | |
| Solid Biosciences Com New (SLDB) | 1.4 | $4.6M | 1.2M | 3.70 | |
| Denali Therapeutics (DNLI) | 1.0 | $3.4M | 250k | 13.60 | |
| Kodiak Sciences (KOD) | 0.9 | $2.9M | 1.0M | 2.81 | |
| Prelude Therapeutics (PRLD) | 0.5 | $1.6M | 2.1M | 0.77 | |
| Instil Bio Com New (TIL) | 0.4 | $1.4M | 80k | 17.36 | |
| Boundless Bio (BOLD) | 0.1 | $378k | 250k | 1.51 | |
| Eliem Therapeutics (CLYM) | 0.1 | $177k | 145k | 1.22 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $85k | 267k | 0.32 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.0k | 67k | 0.03 |
